Chiara Massa - Search Results

Year	Number of Results
2004	1
2005	1
2008	1
2010	3
2011	2
2013	3
2015	4
2016	1
2017	2
2018	1
2019	4
2020	9
2021	5
2022	10
2023	5
2024	0

1

Immune Therapy Resistance and Immune Escape of Tumors.

Seliger B, Massa C. Seliger B, et al. Among authors: massa c. Cancers (Basel). 2021 Feb 1;13(3):551. doi: 10.3390/cancers13030551. Cancers (Basel). 2021. PMID: 33535559 Free PMC article. Review.

2

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.

Vaxevanis CK, Bauer M, Subbarayan K, Friedrich M, Massa C, Biehl K, Al-Ali HK, Wickenhauser C, Seliger B. Vaxevanis CK, et al. Among authors: massa c. Oncoimmunology. 2022 Dec 15;12(1):2152998. doi: 10.1080/2162402X.2022.2152998. eCollection 2023. Oncoimmunology. 2022. PMID: 36531688 Free PMC article.

3

Combination of multiple omics techniques for a personalized therapy or treatment selection.

Massa C, Seliger B. Massa C, et al. Front Immunol. 2023 Sep 27;14:1258013. doi: 10.3389/fimmu.2023.1258013. eCollection 2023. Front Immunol. 2023. PMID: 37828984 Free PMC article. Review.

4

Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways.

Seliger B, Massa C. Seliger B, et al. Among authors: massa c. Front Immunol. 2022 May 19;13:883639. doi: 10.3389/fimmu.2022.883639. eCollection 2022. Front Immunol. 2022. PMID: 35663987 Free PMC article. Review.

5

Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway.

Massa C, Wang Y, Marr N, Seliger B. Massa C, et al. Int J Mol Sci. 2023 Apr 4;24(7):6736. doi: 10.3390/ijms24076736. Int J Mol Sci. 2023. PMID: 37047709 Free PMC article. Review.

6

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.

Schäfer H, Subbarayan K, Massa C, Vaxevanis C, Mueller A, Seliger B. Schäfer H, et al. Among authors: massa c. J Transl Med. 2023 Sep 20;21(1):643. doi: 10.1186/s12967-023-04476-x. J Transl Med. 2023. PMID: 37730606 Free PMC article.

7

Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.

Friedrich M, Jasinski-Bergner S, Lazaridou MF, Subbarayan K, Massa C, Tretbar S, Mueller A, Handke D, Biehl K, Bukur J, Donia M, Mandelboim O, Seliger B. Friedrich M, et al. Among authors: massa c. Cancer Immunol Immunother. 2019 Oct;68(10):1689-1700. doi: 10.1007/s00262-019-02373-1. Epub 2019 Aug 3. Cancer Immunol Immunother. 2019. PMID: 31375885 Review.

8

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.

Seliger B, Massa C, Yang B, Bethmann D, Kappler M, Eckert AW, Wickenhauser C. Seliger B, et al. Among authors: massa c. Int J Mol Sci. 2020 Sep 24;21(19):7032. doi: 10.3390/ijms21197032. Int J Mol Sci. 2020. PMID: 32987799 Free PMC article. Review.

9

Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors.

Seliger B, Massa C, Rini B, Ko J, Finke J. Seliger B, et al. Among authors: massa c. Trends Mol Med. 2010 Apr;16(4):184-92. doi: 10.1016/j.molmed.2010.02.001. Epub 2010 Mar 19. Trends Mol Med. 2010. PMID: 20304705 Review.

10

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection.

Seliger B, Jasinski-Bergner S, Massa C, Mueller A, Biehl K, Yang B, Bachmann M, Jonigk D, Eichhorn P, Hartmann A, Wickenhauser C, Bauer M. Seliger B, et al. Among authors: massa c. Cell Mol Life Sci. 2022 Nov 5;79(11):582. doi: 10.1007/s00018-022-04592-9. Cell Mol Life Sci. 2022. PMID: 36334153 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year